Case Report: Nasal swelling and ulceration as a unique immune-related cutaneous adverse event of atezolizumab in small cell lung cancer - Top-Institutions - MDSpire

Case Report: Nasal swelling and ulceration as a unique immune-related cutaneous adverse event of atezolizumab in small cell lung cancer

By
Junhui Yang
Xuemei Du
Hongyun Liu
Yueqin Hao
April 30, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Medical Oncology
- Dermatology
- Immunotherapy
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Medical Oncology
- Dermatology
- Immuno-Oncology
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Medical Oncology
- Dermatology
- Immunotherapy
#4

Johns Hopkins Hospital

Baltimore, MD
Key Differentiators
- Medical Oncology
- Dermatology
- Immunotherapy
#5

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Medical Oncology
- Dermatology
- Immunotherapy

Original Source(s)

Frontiers In Immunology

Case Report: Nasal swelling and ulceration as a unique immune-related cutaneous adverse event of atezolizumab in small cell lung cancer

by Junhui Yang, Xuemei Du, Hongyun Liu, Yueqin Hao
April 30, 2026

Related Content

Frontiers In Endocrinology

An LDH-based prognostic model for extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy and consolidative thoracic radiotherapy

by Yunuo Zhao, Yuchi Zou, Shengxin Zhang, Yu Zhang, Xueyan Zhou, Shen Li, Yuwen Zhou
May 20, 2026

Jama Network Open

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

by Chuan Angel Lu, Changchuan Jiang, Andrew Z. Wang, Tian Zhang
May 29, 2026

Frontiers In Oncology

Real-world treatment patterns and outcomes for patients with extensive-stage small-cell lung cancer treated in US community oncology practices